ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Weight Loss Pill Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-12O18755
Home | Market Reports | Health| Pharmacy
Global GLP 1 Weight Loss Pill Market Research Report 2024
BUY CHAPTERS

Global GLP-1 Weight Loss Pill Market Research Report 2024

Code: QYRE-Auto-12O18755
Report
December 2024
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Reddy's Laboratories
Merck
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
CSPC Pharmaceuticals
Wanbang Biopharma
IMEIK
Aurisco Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Sihuan Pharmaceuticals

GLP-1 Weight Loss Pill Market Size

The global market for GLP-1 Weight Loss Pill was valued at US$ 1214 million in the year 2023 and is projected to reach a revised size of US$ 2465 million by 2030, growing at a CAGR of 10.7% during the forecast period.

GLP-1 Weight Loss Pill Market

GLP-1 Weight Loss Pill Market

GLP-1 (glucagon-like peptide-1) weight loss drugs are a class of drugs developed based on GLP-1 or its analogs, which are designed to help lose weight by simulating or enhancing the physiological effects of GLP-1. GLP-1 weight loss drugs usually act as GLP-1 receptor agonists. They can bind to GLP-1 receptors in the body, thereby activating the receptors and triggering a series of biological effects. GLP-1 weight loss drugs can suppress appetite, slow gastric emptying, and promote fat metabolism. At present, there are many GLP-1 weight loss drugs on the market, such as liraglutide, benaglutide, semaglutide and Tirzepatide.
North American market for GLP-1 Weight Loss Pill is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for GLP-1 Weight Loss Pill is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of GLP-1 Weight Loss Pill include Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for GLP-1 Weight Loss Pill, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Weight Loss Pill.
The GLP-1 Weight Loss Pill market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GLP-1 Weight Loss Pill market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Weight Loss Pill manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of GLP-1 Weight Loss Pill Market Report

Report Metric Details
Report Name GLP-1 Weight Loss Pill Market
Accounted market size in year US$ 1214 million
Forecasted market size in 2030 US$ 2465 million
CAGR 10.7%
Base Year year
Forecasted years 2025 - 2030
by Type
  • Oral
  • Injection
by Application
  • Hospital
  • Pharmacy
  • Clinic
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, CSPC Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1 Weight Loss Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1 Weight Loss Pill in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is GLP-1 Weight Loss Pill Market growing?

Ans: The GLP-1 Weight Loss Pill Market witnessing a CAGR of 10.7% during the forecast period 2025-2030.

What is the GLP-1 Weight Loss Pill Market size in 2030?

Ans: The GLP-1 Weight Loss Pill Market size in 2030 will be US$ 2465 million.

Who are the main players in the GLP-1 Weight Loss Pill Market report?

Ans: The main players in the GLP-1 Weight Loss Pill Market are Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, CSPC Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik

What are the Application segmentation covered in the GLP-1 Weight Loss Pill Market report?

Ans: The Applications covered in the GLP-1 Weight Loss Pill Market report are Hospital, Pharmacy, Clinic, Others

What are the Type segmentation covered in the GLP-1 Weight Loss Pill Market report?

Ans: The Types covered in the GLP-1 Weight Loss Pill Market report are Oral, Injection

Recommended Reports

GLP-1 Agonists

Anti-obesity Medicines

GLP-1 Diabetic Drugs

1 GLP-1 Weight Loss Pill Market Overview
1.1 Product Definition
1.2 GLP-1 Weight Loss Pill by Type
1.2.1 Global GLP-1 Weight Loss Pill Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injection
1.3 GLP-1 Weight Loss Pill by Application
1.3.1 Global GLP-1 Weight Loss Pill Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global GLP-1 Weight Loss Pill Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Weight Loss Pill Revenue 2019-2030
1.4.2 Global GLP-1 Weight Loss Pill Sales 2019-2030
1.4.3 Global GLP-1 Weight Loss Pill Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GLP-1 Weight Loss Pill Market Competition by Manufacturers
2.1 Global GLP-1 Weight Loss Pill Sales Market Share by Manufacturers (2019-2024)
2.2 Global GLP-1 Weight Loss Pill Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GLP-1 Weight Loss Pill Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GLP-1 Weight Loss Pill, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Weight Loss Pill, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Weight Loss Pill, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Weight Loss Pill, Date of Enter into This Industry
2.8 Global GLP-1 Weight Loss Pill Market Competitive Situation and Trends
2.8.1 Global GLP-1 Weight Loss Pill Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Weight Loss Pill Players Market Share by Revenue
2.8.3 Global GLP-1 Weight Loss Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Weight Loss Pill Market Scenario by Region
3.1 Global GLP-1 Weight Loss Pill Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GLP-1 Weight Loss Pill Sales by Region: 2019-2030
3.2.1 Global GLP-1 Weight Loss Pill Sales by Region: 2019-2024
3.2.2 Global GLP-1 Weight Loss Pill Sales by Region: 2025-2030
3.3 Global GLP-1 Weight Loss Pill Revenue by Region: 2019-2030
3.3.1 Global GLP-1 Weight Loss Pill Revenue by Region: 2019-2024
3.3.2 Global GLP-1 Weight Loss Pill Revenue by Region: 2025-2030
3.4 North America GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.4.1 North America GLP-1 Weight Loss Pill Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GLP-1 Weight Loss Pill Sales by Country (2019-2030)
3.4.3 North America GLP-1 Weight Loss Pill Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.5.1 Europe GLP-1 Weight Loss Pill Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GLP-1 Weight Loss Pill Sales by Country (2019-2030)
3.5.3 Europe GLP-1 Weight Loss Pill Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Weight Loss Pill Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Weight Loss Pill Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GLP-1 Weight Loss Pill Sales by Region (2019-2030)
3.6.3 Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Weight Loss Pill Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GLP-1 Weight Loss Pill Sales by Country (2019-2030)
3.7.3 Latin America GLP-1 Weight Loss Pill Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Weight Loss Pill Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (2019-2030)
3.8.3 Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Weight Loss Pill Sales by Type (2019-2030)
4.1.1 Global GLP-1 Weight Loss Pill Sales by Type (2019-2024)
4.1.2 Global GLP-1 Weight Loss Pill Sales by Type (2025-2030)
4.1.3 Global GLP-1 Weight Loss Pill Sales Market Share by Type (2019-2030)
4.2 Global GLP-1 Weight Loss Pill Revenue by Type (2019-2030)
4.2.1 Global GLP-1 Weight Loss Pill Revenue by Type (2019-2024)
4.2.2 Global GLP-1 Weight Loss Pill Revenue by Type (2025-2030)
4.2.3 Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2019-2030)
4.3 Global GLP-1 Weight Loss Pill Price by Type (2019-2030)
5 Segment by Application
5.1 Global GLP-1 Weight Loss Pill Sales by Application (2019-2030)
5.1.1 Global GLP-1 Weight Loss Pill Sales by Application (2019-2024)
5.1.2 Global GLP-1 Weight Loss Pill Sales by Application (2025-2030)
5.1.3 Global GLP-1 Weight Loss Pill Sales Market Share by Application (2019-2030)
5.2 Global GLP-1 Weight Loss Pill Revenue by Application (2019-2030)
5.2.1 Global GLP-1 Weight Loss Pill Revenue by Application (2019-2024)
5.2.2 Global GLP-1 Weight Loss Pill Revenue by Application (2025-2030)
5.2.3 Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2019-2030)
5.3 Global GLP-1 Weight Loss Pill Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk GLP-1 Weight Loss Pill Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly GLP-1 Weight Loss Pill Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Reddy's Laboratories
6.3.1 Reddy's Laboratories Company Information
6.3.2 Reddy's Laboratories Description and Business Overview
6.3.3 Reddy's Laboratories GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Reddy's Laboratories GLP-1 Weight Loss Pill Product Portfolio
6.3.5 Reddy's Laboratories Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck GLP-1 Weight Loss Pill Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aurisco Pharmaceuticals
6.5.1 Aurisco Pharmaceuticals Company Information
6.5.2 Aurisco Pharmaceuticals Description and Business Overview
6.5.3 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.5.5 Aurisco Pharmaceuticals Recent Developments/Updates
6.6 Huadong Medicine
6.6.1 Huadong Medicine Company Information
6.6.2 Huadong Medicine Description and Business Overview
6.6.3 Huadong Medicine GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Huadong Medicine GLP-1 Weight Loss Pill Product Portfolio
6.6.5 Huadong Medicine Recent Developments/Updates
6.7 Borui Pharmaceuticals
6.7.1 Borui Pharmaceuticals Company Information
6.7.2 Borui Pharmaceuticals Description and Business Overview
6.7.3 Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Borui Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.7.5 Borui Pharmaceuticals Recent Developments/Updates
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Company Information
6.8.2 Hengrui Medicine Description and Business Overview
6.8.3 Hengrui Medicine GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hengrui Medicine GLP-1 Weight Loss Pill Product Portfolio
6.8.5 Hengrui Medicine Recent Developments/Updates
6.9 Innovent Biologics
6.9.1 Innovent Biologics Company Information
6.9.2 Innovent Biologics Description and Business Overview
6.9.3 Innovent Biologics GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Innovent Biologics GLP-1 Weight Loss Pill Product Portfolio
6.9.5 Innovent Biologics Recent Developments/Updates
6.10 Shanghai Benemae Biopharmaceuticals Co., Ltd.
6.10.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
6.10.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
6.10.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product Portfolio
6.10.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
6.11 Hansoh Pharmaceuticals
6.11.1 Hansoh Pharmaceuticals Company Information
6.11.2 Hansoh Pharmaceuticals Description and Business Overview
6.11.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.11.5 Hansoh Pharmaceuticals Recent Developments/Updates
6.12 Gan & Lee Pharmaceuticals
6.12.1 Gan & Lee Pharmaceuticals Company Information
6.12.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.12.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.12.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.13 CSPC Pharmaceuticals
6.13.1 CSPC Pharmaceuticals Company Information
6.13.2 CSPC Pharmaceuticals Description and Business Overview
6.13.3 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.13.5 CSPC Pharmaceuticals Recent Developments/Updates
6.14 Wanbang Biopharma
6.14.1 Wanbang Biopharma Company Information
6.14.2 Wanbang Biopharma Description and Business Overview
6.14.3 Wanbang Biopharma GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Wanbang Biopharma GLP-1 Weight Loss Pill Product Portfolio
6.14.5 Wanbang Biopharma Recent Developments/Updates
6.15 Sihuan Pharmaceuticals
6.15.1 Sihuan Pharmaceuticals Company Information
6.15.2 Sihuan Pharmaceuticals Description and Business Overview
6.15.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.15.5 Sihuan Pharmaceuticals Recent Developments/Updates
6.16 Imeik
6.16.1 Imeik Company Information
6.16.2 Imeik Description and Business Overview
6.16.3 Imeik GLP-1 Weight Loss Pill Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Imeik GLP-1 Weight Loss Pill Product Portfolio
6.16.5 Imeik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Weight Loss Pill Industry Chain Analysis
7.2 GLP-1 Weight Loss Pill Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Weight Loss Pill Production Mode & Process
7.4 GLP-1 Weight Loss Pill Sales and Marketing
7.4.1 GLP-1 Weight Loss Pill Sales Channels
7.4.2 GLP-1 Weight Loss Pill Distributors
7.5 GLP-1 Weight Loss Pill Customers
8 GLP-1 Weight Loss Pill Market Dynamics
8.1 GLP-1 Weight Loss Pill Industry Trends
8.2 GLP-1 Weight Loss Pill Market Drivers
8.3 GLP-1 Weight Loss Pill Market Challenges
8.4 GLP-1 Weight Loss Pill Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Reddy's Laboratories
Merck
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
CSPC Pharmaceuticals
Wanbang Biopharma
IMEIK
Aurisco Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Sihuan Pharmaceuticals
List of Tables
 Table 1. Global GLP-1 Weight Loss Pill Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global GLP-1 Weight Loss Pill Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global GLP-1 Weight Loss Pill Market Competitive Situation by Manufacturers in 2023
 Table 4. Global GLP-1 Weight Loss Pill Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global GLP-1 Weight Loss Pill Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global GLP-1 Weight Loss Pill Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market GLP-1 Weight Loss Pill Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of GLP-1 Weight Loss Pill, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1 Weight Loss Pill, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Weight Loss Pill, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1 Weight Loss Pill, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Weight Loss Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Weight Loss Pill as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Weight Loss Pill Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global GLP-1 Weight Loss Pill Sales by Region (2019-2024) & (K Units)
 Table 18. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2019-2024)
 Table 19. Global GLP-1 Weight Loss Pill Sales by Region (2025-2030) & (K Units)
 Table 20. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2025-2030)
 Table 21. Global GLP-1 Weight Loss Pill Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global GLP-1 Weight Loss Pill Revenue Market Share by Region (2019-2024)
 Table 23. Global GLP-1 Weight Loss Pill Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global GLP-1 Weight Loss Pill Revenue Market Share by Region (2025-2030)
 Table 25. North America GLP-1 Weight Loss Pill Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America GLP-1 Weight Loss Pill Sales by Country (2019-2024) & (K Units)
 Table 27. North America GLP-1 Weight Loss Pill Sales by Country (2025-2030) & (K Units)
 Table 28. North America GLP-1 Weight Loss Pill Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America GLP-1 Weight Loss Pill Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe GLP-1 Weight Loss Pill Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe GLP-1 Weight Loss Pill Sales by Country (2019-2024) & (K Units)
 Table 32. Europe GLP-1 Weight Loss Pill Sales by Country (2025-2030) & (K Units)
 Table 33. Europe GLP-1 Weight Loss Pill Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe GLP-1 Weight Loss Pill Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific GLP-1 Weight Loss Pill Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific GLP-1 Weight Loss Pill Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America GLP-1 Weight Loss Pill Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America GLP-1 Weight Loss Pill Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America GLP-1 Weight Loss Pill Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America GLP-1 Weight Loss Pill Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America GLP-1 Weight Loss Pill Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global GLP-1 Weight Loss Pill Sales (K Units) by Type (2019-2024)
 Table 51. Global GLP-1 Weight Loss Pill Sales (K Units) by Type (2025-2030)
 Table 52. Global GLP-1 Weight Loss Pill Sales Market Share by Type (2019-2024)
 Table 53. Global GLP-1 Weight Loss Pill Sales Market Share by Type (2025-2030)
 Table 54. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2019-2024)
 Table 57. Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2025-2030)
 Table 58. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2019-2024)
 Table 59. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2025-2030)
 Table 60. Global GLP-1 Weight Loss Pill Sales (K Units) by Application (2019-2024)
 Table 61. Global GLP-1 Weight Loss Pill Sales (K Units) by Application (2025-2030)
 Table 62. Global GLP-1 Weight Loss Pill Sales Market Share by Application (2019-2024)
 Table 63. Global GLP-1 Weight Loss Pill Sales Market Share by Application (2025-2030)
 Table 64. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2019-2024)
 Table 67. Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2025-2030)
 Table 68. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2019-2024)
 Table 69. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2025-2030)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Novo Nordisk GLP-1 Weight Loss Pill Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eli Lilly GLP-1 Weight Loss Pill Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Reddy's Laboratories Company Information
 Table 81. Reddy's Laboratories Description and Business Overview
 Table 82. Reddy's Laboratories GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Reddy's Laboratories GLP-1 Weight Loss Pill Product
 Table 84. Reddy's Laboratories Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Merck GLP-1 Weight Loss Pill Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Aurisco Pharmaceuticals Company Information
 Table 91. Aurisco Pharmaceuticals Description and Business Overview
 Table 92. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 94. Aurisco Pharmaceuticals Recent Developments/Updates
 Table 95. Huadong Medicine Company Information
 Table 96. Huadong Medicine Description and Business Overview
 Table 97. Huadong Medicine GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Huadong Medicine GLP-1 Weight Loss Pill Product
 Table 99. Huadong Medicine Recent Developments/Updates
 Table 100. Borui Pharmaceuticals Company Information
 Table 101. Borui Pharmaceuticals Description and Business Overview
 Table 102. Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Borui Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 104. Borui Pharmaceuticals Recent Developments/Updates
 Table 105. Hengrui Medicine Company Information
 Table 106. Hengrui Medicine Description and Business Overview
 Table 107. Hengrui Medicine GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Hengrui Medicine GLP-1 Weight Loss Pill Product
 Table 109. Hengrui Medicine Recent Developments/Updates
 Table 110. Innovent Biologics Company Information
 Table 111. Innovent Biologics Description and Business Overview
 Table 112. Innovent Biologics GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Innovent Biologics GLP-1 Weight Loss Pill Product
 Table 114. Innovent Biologics Recent Developments/Updates
 Table 115. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
 Table 116. Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
 Table 117. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product
 Table 119. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 120. Hansoh Pharmaceuticals Company Information
 Table 121. Hansoh Pharmaceuticals Description and Business Overview
 Table 122. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 124. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 125. Gan & Lee Pharmaceuticals Company Information
 Table 126. Gan & Lee Pharmaceuticals Description and Business Overview
 Table 127. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 129. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 130. CSPC Pharmaceuticals Company Information
 Table 131. CSPC Pharmaceuticals Description and Business Overview
 Table 132. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 134. CSPC Pharmaceuticals Recent Developments/Updates
 Table 135. Wanbang Biopharma Company Information
 Table 136. Wanbang Biopharma Description and Business Overview
 Table 137. Wanbang Biopharma GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Wanbang Biopharma GLP-1 Weight Loss Pill Product
 Table 139. Wanbang Biopharma Recent Developments/Updates
 Table 140. Sihuan Pharmaceuticals Company Information
 Table 141. Sihuan Pharmaceuticals Description and Business Overview
 Table 142. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 144. Sihuan Pharmaceuticals Recent Developments/Updates
 Table 145. Imeik Company Information
 Table 146. Imeik Description and Business Overview
 Table 147. Imeik GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Imeik GLP-1 Weight Loss Pill Product
 Table 149. Imeik Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. GLP-1 Weight Loss Pill Distributors List
 Table 153. GLP-1 Weight Loss Pill Customers List
 Table 154. GLP-1 Weight Loss Pill Market Trends
 Table 155. GLP-1 Weight Loss Pill Market Drivers
 Table 156. GLP-1 Weight Loss Pill Market Challenges
 Table 157. GLP-1 Weight Loss Pill Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Weight Loss Pill
 Figure 2. Global GLP-1 Weight Loss Pill Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global GLP-1 Weight Loss Pill Market Share by Type: 2023 & 2030
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global GLP-1 Weight Loss Pill Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global GLP-1 Weight Loss Pill Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global GLP-1 Weight Loss Pill Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global GLP-1 Weight Loss Pill Market Size (2019-2030) & (US$ Million)
 Figure 14. Global GLP-1 Weight Loss Pill Sales (2019-2030) & (K Units)
 Figure 15. Global GLP-1 Weight Loss Pill Average Price (US$/Unit) & (2019-2030)
 Figure 16. GLP-1 Weight Loss Pill Report Years Considered
 Figure 17. GLP-1 Weight Loss Pill Sales Share by Manufacturers in 2023
 Figure 18. Global GLP-1 Weight Loss Pill Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest GLP-1 Weight Loss Pill Players: Market Share by Revenue in GLP-1 Weight Loss Pill in 2023
 Figure 20. GLP-1 Weight Loss Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global GLP-1 Weight Loss Pill Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America GLP-1 Weight Loss Pill Sales Market Share by Country (2019-2030)
 Figure 23. North America GLP-1 Weight Loss Pill Revenue Market Share by Country (2019-2030)
 Figure 24. United States GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe GLP-1 Weight Loss Pill Sales Market Share by Country (2019-2030)
 Figure 27. Europe GLP-1 Weight Loss Pill Revenue Market Share by Country (2019-2030)
 Figure 28. Germany GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific GLP-1 Weight Loss Pill Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific GLP-1 Weight Loss Pill Revenue Market Share by Region (2019-2030)
 Figure 35. China GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America GLP-1 Weight Loss Pill Sales Market Share by Country (2019-2030)
 Figure 43. Mexico GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa GLP-1 Weight Loss Pill Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa GLP-1 Weight Loss Pill Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE GLP-1 Weight Loss Pill Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of GLP-1 Weight Loss Pill by Type (2019-2030)
 Figure 53. Global Revenue Market Share of GLP-1 Weight Loss Pill by Type (2019-2030)
 Figure 54. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of GLP-1 Weight Loss Pill by Application (2019-2030)
 Figure 56. Global Revenue Market Share of GLP-1 Weight Loss Pill by Application (2019-2030)
 Figure 57. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2019-2030)
 Figure 58. GLP-1 Weight Loss Pill Value Chain
 Figure 59. GLP-1 Weight Loss Pill Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global GLP 1 Weight Loss Injection Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1 based Therapy Market Research Report 2024
Global GLP 1 Drugs Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Injection Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions